REPATHA (Evolocumab)

**Product type:** Human Prescription Drug

**Active ingredient:** EVOLOCUMAB

**Strength:** 140 mg/mL

**Dosage form:** Injection, Solution

**Route:** Subcutaneous

**Labeler:** Amgen USA Inc.

**Marketing category:** BLA (BLA125522)

**Pharmacologic class:** Antibodies, Monoclonal [CS], PCSK9 Inhibitor [EPC], PCSK9 Inhibitors [MoA]